Henko Partners closes its second fund after raising €175 million

The private equity fund raises its second €175 million fund (Henko Capital Partners II, FCRE) to support Spanish and Portuguese SMEs in growth projects. Madrid, 7 October 2024. - Less than three years after setting up its first fund at the end of 2021, Henko Partners has completed the final closing of [...]

Henko Annual Review 2023

Madrid, January 18th 2023. - 2023 is behind us and we have recharged our batteries during the Christmas holidays. Now we are back to work and want to share a short summary of the third year of Henko Partners! This is what 2023 was like for us... New investments Link: Leading IT consulting company in Portugal that has [...]

Quadrante shareholders and Henko Partners join forces to position Quadrante as a leading global sustainability engineer

Henko Partners invests in Quadrante, a leading Portuguese environmental engineering and consultancy company Quadrante's shareholders will lead the execution of the growth strategy, based on the integration of companies that complement the current portfolio of services and open up new markets Henko will support Quadrante's international expansion, creating an integrated platform of services that will allow the company to [...]

Henko Partners launches AstrumCRO after investing in BlueClinical and Pharmalog

The newly integrated companies form a pan-European CRO together with Henko portfolio companies BioClever and PopsiCube. Pharmalog, based in Munich, is a fast-growing CRO with a team of more than 50 professionals specialised in full service clinical trials in the DACH region. BlueClinical, based in Porto, is a CRO [...]

Henko Partners continues to strengthen the leadership team for its new emerging pan-European CRO with Ethel Vissers as Chief Commercial Officer, and Carlos Faro as Chief Financial Officer.

  Madrid, October 29th, 2023. - Henko Partners, an Iberian private equity firm, is delighted to announce two appointments to reinforce the corporate team that will be supporting the growth and international expansion of its emerging pan-European CRO. Ethel Vissers brings over 20 years of experience in commercial leadership roles within large leading Contract Research and [...]